Adjuvant Therapy for the Treatment of Breast Cancer
Created 5 months ago by anniepery

Trastuzumab is approved for the treatment of early-stage as well as advanced breast cancer. It is often prescribed with chemo, but it might also be administered alone. The trastuzumab price is reasonable at every ISO & GDP certified pharmaceutical wholesaler/pharmacy. When initiated before (neoadjuvant) or after (adjuvant) surgery in order to treat early breast cancer, trastuzumab is usually given for 6 to 12 months. In order to treat advanced breast cancer, trastuzumab therapy is often used for as long as the medication is effective. The recommended dose of trastuzumab is administered into a vein (IV).